John B. Whelan

2012

In 2012, John B. Whelan earned a total compensation of $530.8K as Former President and Chief Executive Officer; current Chief Financial Officer at Heron Therapeutics, a 91% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$128,400
Salary$395,000
Other$7,500
Total$530,750

Whelan received $395K in salary, accounting for 74% of the total pay in 2012.

Whelan also received $128.4K in non-equity incentive plan and $7.5K in other compensation.

Rankings

In 2012, John B. Whelan's compensation ranked 8,581st out of 11,487 executives tracked by ExecPay. In other words, Whelan earned more than 25.3% of executives.

ClassificationRankingPercentile
All
8,581
out of 11,487
25th
Division
Manufacturing
3,116
out of 4,253
27th
Major group
Chemicals And Allied Products
833
out of 1,198
31st
Industry group
Drugs
608
out of 920
34th
Industry
Pharmaceutical Preparations
476
out of 700
32nd
Source: SEC filing on May 9, 2013.

Whelan's colleagues

We found three more compensation records of executives who worked with John B. Whelan at Heron Therapeutics in 2012.

2012

Robert Rosen

Heron Therapeutics

Former Senior Vice President and Chief Commercial Officer; current President

2012

Mark Gelder

Heron Therapeutics

Chief Medical Officer

2012

Michael Adam

Heron Therapeutics

Chief Operating Officer

You may also like